Terms: = Colorectal cancer AND MUC16, CA125, CA-125 AND Prognosis
56 results:
1. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
Tan Y; Liu R; Xue JW; Feng Z
Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
[TBL] [Abstract] [Full Text] [Related]
2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
3. Differential genetic mutations and immune cell infiltration in high- and low-risk STAD: Implications for prognosis and immunotherapy efficacy.
Deng YY; Sun Y; Wu SJ; Zhang TY; Yang J; Liu K
J Cell Mol Med; 2024 Apr; 28(7):e18174. PubMed ID: 38494839
[TBL] [Abstract] [Full Text] [Related]
4. Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma.
Sun W; Liu K; Zhou H; Zhao F; Dong Y; Xu Y; Kong Y; Wang M; Cheng X; Chen Y
Med Oncol; 2023 Oct; 40(11):330. PubMed ID: 37831226
[TBL] [Abstract] [Full Text] [Related]
5. Histopathology and levels of proteins in plasma associate with survival after colorectal cancer diagnosis.
Magnusson MI; Agnarsson BA; Jonasson JG; Tryggvason T; Aeffner F; le Roux L; Magnusdottir DN; Gunnarsdottir HS; Alexíusdóttir KK; Gunnarsdottir K; Söebech E; Runarsdottir H; Jonsdottir EM; Kristinsdottir BS; Olafsson S; Knutsdottir H; Thorsteinsdottir U; Ulfarsson MO; Gudbjartsson DF; Saemundsdottir J; Magnusson OT; Norddahl GL; Watson JEV; Rafnar T; Lund SH; Stefansson K
Br J Cancer; 2023 Oct; 129(7):1142-1151. PubMed ID: 37596405
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic role of metabolic 18F-FDG PET/CT parameters and hematological prognostic indicators in patients with colorectal cancer.
Cengiz A; Yersal Ö; Ömürlü İK; Yürekli Y
Indian J Cancer; 2023; 60(2):224-229. PubMed ID: 37530245
[TBL] [Abstract] [Full Text] [Related]
7. Electrochemical biotool for the dual determination of epithelial mucins associated to prognosis and minimal residual disease in colorectal cancer.
Tejerina-Miranda S; Blázquez-García M; Serafín V; Montero-Calle A; Garranzo-Asensio M; Reviejo AJ; Pedrero M; Pingarrón JM; Barderas R; Campuzano S
Int J Biol Macromol; 2023 Sep; 248():125996. PubMed ID: 37499706
[TBL] [Abstract] [Full Text] [Related]
8. Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data.
Cao L; Zhang S; Yao D; Ba Y; Weng Q; Yang J; Zhang H; Ren Y
Aging (Albany NY); 2023 Jul; 15(14):7098-7123. PubMed ID: 37480572
[TBL] [Abstract] [Full Text] [Related]
9. Circulating extracellular vesicle-derived MARCKSL1 is a potential diagnostic non-invasive biomarker in metastatic colorectal cancer patients.
Rong W; Shao S; Pu Y; Ji Q; Zhu H
Sci Rep; 2023 Jun; 13(1):9957. PubMed ID: 37340044
[TBL] [Abstract] [Full Text] [Related]
10. D-dimer to lymphocyte ratio can serve as a potential predictive and prognostic value in colorectal cancer patients with liver metastases.
Lu S; Gong S; Wu F; Ma L; Xiang B; Li L; Tang W
BMC Surg; 2023 Mar; 23(1):64. PubMed ID: 36966285
[TBL] [Abstract] [Full Text] [Related]
11. Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study.
Li C; Zhao K; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
BMC Med; 2023 Feb; 21(1):63. PubMed ID: 36803500
[TBL] [Abstract] [Full Text] [Related]
12. The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours.
Ain QU; Muhammad S; Hai Y; Peiling L
J Obstet Gynaecol; 2022 Nov; 42(8):3441-3449. PubMed ID: 36757337
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of Prognostic Factors of Rectal cancer and Construction of a Prognostic Prediction Model Based on Bayesian Network.
Li R; Zhang C; Du K; Dan H; Ding R; Cai Z; Duan L; Xie Z; Zheng G; Wu H; Ren G; Dou X; Feng F; Zheng J
Front Public Health; 2022; 10():842970. PubMed ID: 35784233
[TBL] [Abstract] [Full Text] [Related]
14. The association of clinicopathological characterizations of colorectal cancer with membrane-bound mucins genes and LncRNAs.
Iranmanesh H; Entezari M; Rejali L; Nazemalhosseini-Mojarad E; Maghsoudloo M; Aghdaei HA; Zali MR; Hushmandi K; Rabiee N; Makvandi P; Ashrafizadeh M; Hashemi M
Pathol Res Pract; 2022 May; 233():153883. PubMed ID: 35452967
[TBL] [Abstract] [Full Text] [Related]
15. Trajectories of Perioperative Serum Tumor Markers and colorectal cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study.
Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T
EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967
[TBL] [Abstract] [Full Text] [Related]
16. Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for colorectal cancer.
Xie J; Huang Z; Jiang P; Wu R; Jiang H; Luo C; Hong H; Yin H
Front Immunol; 2021; 12():760747. PubMed ID: 34659267
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Pathways Associated with Kallikrein 6 Overexpression in colorectal cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract] [Full Text] [Related]
18. Mucin 16 Promotes colorectal cancer Development and Progression Through Activation of Janus Kinase 2.
Liu Z; Gu Y; Li X; Zhou L; Cheng X; Jiang H; Huang Y; Zhang Y; Xu T; Yang W; Huang Q
Dig Dis Sci; 2022 Jun; 67(6):2195-2208. PubMed ID: 33982216
[TBL] [Abstract] [Full Text] [Related]
19. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
[TBL] [Abstract] [Full Text] [Related]
20. Clinicopathological Analysis and Prognostic Assessment of Transcobalamin I (TCN1) in Patients with colorectal Tumors.
Zhu X; Yi K; Hou D; Huang H; Jiang X; Shi X; Xing C
Med Sci Monit; 2020 Jul; 26():e923828. PubMed ID: 32753569
[TBL] [Abstract] [Full Text] [Related]
[Next]
